title: Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.
abstract: The temporal sequence of coronavirus plus-strand and minus-strand RNA synthesis was determined in 17CL1 cells infected with the A59 strain of mouse hepatitis virus (MHV). MHV-induced fusion was prevented by keeping the pH of the medium below pH 6.8. This had no effect on the MHV replication cycle, but gave 5- to 10-fold-greater titers of infectious virus and delayed the detachment of cells from the monolayer which permitted viral RNA synthesis to be studied conveniently until at least 10 h postinfection. Seven species of poly(A)-containing viral RNAs were synthesized at early and late times after infection, in nonequal but constant ratios. MHV minus-strand RNA synthesis was first detected at about 3 h after infection and was found exclusively in the viral replicative intermediates and was not detected in 60S single-stranded form in infected cells. Early in the replication cycle, from 45 to 65% of the [3H]uridine pulse-labeled RF core of purified MHV replicative intermediates was in minus-strand RNA. The rate of minus-strand synthesis peaked at 5 to 6 h postinfection and then declined to about 20% of the maximum rate. The addition of cycloheximide before 3 h postinfection prevented viral RNA synthesis, whereas the addition of cycloheximide after viral RNA synthesis had begun resulted in the inhibition of viral RNA synthesis. The synthesis of both genome and subgenomic mRNAs and of viral minus strands required continued protein synthesis, and minus-strand RNA synthesis was three- to fourfold more sensitive to inhibition by cycloheximide than was plus-strand synthesis.
authors.forename: S G
authors.initials: SG
authors.lastname: Sawicki
authors.forename: D L
authors.initials: DL
authors.lastname: Sawicki
mesh_terms: D000818:Animals; D002459:Cell Fusion; D002460:Cell Line; D003513:Cycloheximide / Q000494:pharmacology*; D003864:Depression, Chemical; D006863:Hydrogen-Ion Concentration; D051379:Mice; D006517:Murine hepatitis virus / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D011061:Poly A / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis*; D012367:RNA, Viral / Q000096:biosynthesis*; D012324:RNA-Dependent RNA Polymerase / Q000378:metabolism / Q000502:physiology; D013997:Time Factors; D014764:Viral Proteins / Q000378:metabolism / Q000502:physiology; D014779:Virus Replication
chemical_list: D012333:RNA, Messenger; D012367:RNA, Viral; D014764:Viral Proteins; D011061:Poly A; D003513:Cycloheximide; D012324:RNA-Dependent RNA Polymerase